Murphy, Sean M.

Publications

Sort by

Co-Author Network

selected publications

Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019. Health services research. 2023 Academic Article GET IT
Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder. Psychiatric services (Washington, D.C.). 2023 Academic Article GET IT
Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration. Addiction science & clinical practice. 2023 Academic Article GET IT
Racial/Ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City. Research square. 2023 Article GET IT
Times cited: 2
Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2023 Academic Article GET IT
Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study. Journal of substance use and addiction treatment. 2023 Academic Article GET IT
Times cited: 8
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts. JAMA network open. 2023 Academic Article GET IT
Times cited: 1
Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder. JAMA network open. 2023 Academic Article GET IT
Times cited: 3
Budget impact tool for the incorporation of medications for opioid use disorder into jail/prison facilities. Journal of substance use and addiction treatment. 2023 Academic Article GET IT
Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems. BMC health services research. 2022 Academic Article GET IT
Econometric Issues in Prospective Economic Evaluations Alongside Clinical Trials: Combining the Nonparametric Bootstrap With Methods That Address Missing Data. Epidemiologic reviews. 2022 Review GET IT
Times cited: 4
Contingency Management and Pre-Exposure Prophylaxis Adherence Support Services (CoMPASS): A hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs. Contemporary clinical trials. 2022 Academic Article GET IT
Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug and alcohol dependence. 2022 Review GET IT
Times cited: 2
Stakeholder outcome prioritization in the Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA) trial. Health expectations : an international journal of public participation in health care and health policy. 2022 Academic Article GET IT
Times cited: 1
Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17. Addiction (Abingdon, England). 2022 Academic Article GET IT
Times cited: 3
Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island. JAMA network open. 2022 Academic Article GET IT
Times cited: 1
Estimating Absenteeism Related to Nonalcohol Substance Use in a US National Cohort of Full-Time Employees. Journal of occupational and environmental medicine. 2022 Academic Article GET IT
Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts. Drug and alcohol dependence. 2022 Academic Article GET IT
Times cited: 3
The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City. Drug and alcohol dependence reports. 2022 Academic Article GET IT
Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections. Therapeutic advances in infectious disease. 2022 Academic Article GET IT
Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic. Advances in therapy. 2022 Academic Article GET IT
Times cited: 3
Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release. Journal of substance abuse treatment. 2022 Academic Article GET IT
Times cited: 1
The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study. Addiction (Abingdon, England). 2022 Academic Article GET IT
Times cited: 4
Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis. Addiction (Abingdon, England). 2022 Academic Article GET IT
Times cited: 1
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs. Drug and alcohol dependence. 2022 Academic Article GET IT
Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale. Contemporary clinical trials. 2022 Academic Article GET IT
Times cited: 2
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction (Abingdon, England). 2021 Academic Article GET IT
Times cited: 2
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. The International journal on drug policy. 2021 Academic Article GET IT
Times cited: 6
Real-world changes in US health system hospital-based services following treatment with a prescription digital therapeutic for opioid use disorder. Hospital practice (1995). 2021 Academic Article GET IT
Times cited: 4
Patient Activation, Depressive Symptoms, and Self-Rated Health: Care Management Intervention Effects among High-Need, Medically Complex Adults. International journal of environmental research and public health. 2021 Academic Article GET IT
Times cited: 1
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug and alcohol dependence. 2021 Academic Article GET IT
Times cited: 12
Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis. Addiction (Abingdon, England). 2021 Academic Article GET IT
Times cited: 1
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2021 Academic Article GET IT
Times cited: 11
Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression. Translational psychiatry. 2021 Academic Article GET IT
Times cited: 5
Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease. Crohn's & colitis 360. 2021 Academic Article GET IT
Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research. Substance abuse treatment, prevention, and policy. 2021 Academic Article GET IT
A SMARTTT approach to Treating Tobacco use disorder in persons with HIV (SMARTTT): Rationale and design for a hybrid type 1 effectiveness-implementation study. Contemporary clinical trials. 2021 Academic Article GET IT
Times cited: 6
The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation. Contemporary clinical trials. 2021 Academic Article GET IT
Times cited: 9
Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA network open. 2021 Academic Article GET IT
Times cited: 23
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addiction science & clinical practice. 2021 Academic Article GET IT
Times cited: 13
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail. Journal of substance abuse treatment. 2021 Academic Article GET IT
Times cited: 13
Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study. Trials. 2021 Academic Article GET IT
Times cited: 6
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN). Journal of substance abuse treatment. 2021 Academic Article GET IT
Times cited: 15
Health economic analyses of the justice community opioid innovation network (JCOIN). Journal of substance abuse treatment. 2021 Academic Article GET IT
Times cited: 2
Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorder. Journal of medical economics. 2021 Academic Article GET IT
Times cited: 11
Mental Health Costs of Inflammatory Bowel Diseases. Inflammatory bowel diseases. 2021 Academic Article GET IT
Times cited: 24
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail. Journal of substance abuse treatment. 2020 Academic Article GET IT
Times cited: 7
Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting. JAMA network open. 2020 Academic Article GET IT
Times cited: 12
The cost of opioid use disorder and the value of aversion. Drug and alcohol dependence. 2020 Academic Article GET IT
Times cited: 19
Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic. Journal of substance abuse treatment. 2020 Academic Article GET IT
Times cited: 17
Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study. Drug and alcohol dependence. 2020 Academic Article GET IT
Times cited: 7
Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trial. Drug and alcohol dependence. 2020 Academic Article GET IT
Times cited: 8
Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflammatory bowel diseases. 2020 Academic Article GET IT
Times cited: 5
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations. Contemporary clinical trials. 2020 Academic Article GET IT
Times cited: 9
Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials. Addiction science & clinical practice. 2020 Academic Article GET IT
Times cited: 6
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Academic Article GET IT
Times cited: 6
Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial. Contemporary clinical trials. 2020 Academic Article GET IT
Times cited: 5
Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future. Journal of substance abuse treatment. 2020 Academic Article GET IT
Times cited: 5
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. Inflammatory bowel diseases. 2020 Academic Article GET IT
Times cited: 202
Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. Journal of substance abuse treatment. 2019 Academic Article GET IT
Times cited: 18
Medical marijuana laws are associated with increases in substance use treatment admissions by pregnant women. Addiction (Abingdon, England). 2019 Academic Article GET IT
Times cited: 18
Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH). Implementation science : IS. 2019 Academic Article GET IT
Times cited: 34
Will converting naloxone to over-the-counter status increase pharmacy sales?. Health services research. 2019 Academic Article GET IT
Times cited: 16
Emergency department utilization among individuals with idiopathic intracranial hypertension. International journal of health care quality assurance. 2019 Academic Article GET IT
Times cited: 6
Assessing the Interest and Cultural Congruence of Contingency Management as an Intervention for Alcohol Misuse Among Younger American Indian Adults. American Indian and Alaska native mental health research (Online). 2019 Academic Article GET IT
Times cited: 2
Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse. Annals of internal medicine. 2018 Academic Article GET IT
Times cited: 37
Cost of pharmacotherapy for opioid use disorders following inpatient detoxification. The American journal of managed care. 2018 Academic Article GET IT
Times cited: 10
The "Real" Number of Washington State Adolescents Using Marijuana, and Why: A Misclassification Analysis. Substance use & misuse. 2018 Academic Article GET IT
Times cited: 5
Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs. Pain medicine (Malden, Mass.). 2018 Academic Article GET IT
Times cited: 18
Criminal justice measures for economic data harmonization in substance use disorder research. Health & justice. 2018 Academic Article GET IT
Times cited: 1
An Economic Evaluation of Coordinated Specialty Care (CSC) Services for First-Episode Psychosis in the U.S. Public Sector. The journal of mental health policy and economics. 2018 Academic Article GET IT
Times cited: 8
Predictors of tobacco and alcohol co-use from ages 15 to 32: The Amsterdam Growth and Health Longitudinal Study. Experimental and clinical psychopharmacology. 2018 Academic Article GET IT
Times cited: 3
Decreases in smoking during treatment for methamphetamine-use disorders: preliminary evidence. Behavioural pharmacology. 2018 Academic Article GET IT
Times cited: 9
Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness. Contemporary clinical trials. 2018 Academic Article GET IT
Times cited: 1
Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision. Journal of empirical research on human research ethics : JERHRE. 2018 Academic Article GET IT
Times cited: 3
Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned. Substance abuse. 2018 Academic Article GET IT
Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision. Journal of substance abuse treatment. 2017 Academic Article GET IT
Times cited: 5
A Randomized Controlled Trial of a Citywide Emergency Department Care-Coordination Program to Reduce Prescription Opioid-Related Visits: An Economic Evaluation. The Journal of emergency medicine. 2017 Academic Article GET IT
Times cited: 8
Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder. Addiction (Abingdon, England). 2017 Academic Article GET IT
Times cited: 30
Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?. Journal of substance abuse treatment. 2017 Academic Article GET IT
Times cited: 20
The Cost of Nurse-Midwifery Care: Use of Interventions, Resources, and Associated Costs in the Hospital Setting. Women's health issues : official publication of the Jacobs Institute of Women's Health. 2017 Academic Article GET IT
Times cited: 22
Implementation of methadone therapy for opioid use disorder in Russia - a modeled cost-effectiveness analysis. Substance abuse treatment, prevention, and policy. 2017 Academic Article GET IT
Times cited: 18
Urban Blight Remediation as a Cost-Beneficial Solution to Firearm Violence. American journal of public health. 2016 Academic Article GET IT
Times cited: 91
A Randomized Controlled Trial of a Citywide Emergency Department Care Coordination Program to Reduce Prescription Opioid Related Emergency Department Visits. The Journal of emergency medicine. 2016 Academic Article GET IT
Times cited: 24
Economic Evaluations of Opioid Use Disorder Interventions. PharmacoEconomics. 2016 Review GET IT
Times cited: 65
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. The New England journal of medicine. 2016 Academic Article GET IT
Times cited: 222
Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2016 Academic Article GET IT
Times cited: 30
Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial. Drug and alcohol dependence. 2016 Academic Article GET IT
Times cited: 31
Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials. Journal of substance abuse treatment. 2015 Academic Article GET IT
Times cited: 8
An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness. Drug and alcohol dependence. 2015 Academic Article GET IT
Times cited: 22
Opioid misuse among adolescents: new evidence from a misclassification analysis. Applied health economics and health policy. 2015 Academic Article GET IT
Times cited: 13
Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings. The American journal of drug and alcohol abuse. 2015 Academic Article GET IT
Times cited: 9
Prevalence of persistent pain in the U.S. adult population: new data from the 2010 national health interview survey. The journal of pain. 2014 Academic Article GET IT
Times cited: 199
Cost-effective: emergency department care coordination with a regional hospital information system. The Journal of emergency medicine. 2014 Academic Article GET IT
Times cited: 25
Does individualized health information regarding alcohol consumption affect consumption among risky drinkers?. American journal of health promotion : AJHP. 2014 Academic Article GET IT
Times cited: 2
Charity care in nonprofit urban hospitals: analysis of the role of size and ownership type in Washington State for 2011. Journal of healthcare management / American College of Healthcare Executives. 2014 Academic Article GET IT
Times cited: 5
Non-medical prescription opioid use and violent behaviour among adolescents. Journal of child and adolescent mental health. 2014 Academic Article GET IT
Times cited: 20
Determinants of buprenorphine treatment for opioid dependence. Journal of substance abuse treatment. 2013 Academic Article GET IT
Times cited: 21
Determinants of adolescent suicidal ideation: rural versus urban. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2013 Academic Article GET IT
Times cited: 18
What is the impact of health reforms on uncompensated care in critical access hospitals? A 5-year forecast in Washington State. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2011 Academic Article GET IT
Times cited: 5
Measuring shared inefficiency between hospital cost centers. Medical care research and review : MCRR. 2010 Academic Article GET IT
Times cited: 5
Determining factors in the treatment choice of patients with hypertension with complications and secondary hypertension. International journal of health care quality assurance. 2009 Academic Article GET IT

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Health and Economic Outcomes of Treatment with Extended-Release Naltrexone Among Pre-Release Prisoners with Opioid Use Disorder awarded by National Institute on Drug Abuse Principal Investigator 2019 - 2024
Impact of Jail-Based Methadone on Overdose, Recidivism, HIV and Health Outcomes, and Costs in New York City, 2011-2017 awarded by New York City Department of Health & Mental Hygiene Principal Investigator 2019 - 2023

The Economic Viability and Value of Implementing an Inpatient Addiction Consult Model in Public Hospital Systems for Patients with Opioid Use Disorder awarded by National Institute on Drug Abuse Co-Investigator 2023 - 2025
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities awarded by National Institute on Drug Abuse Co-Investigator 2020 - 2025
DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND) awarded by National Institute on Drug Abuse Co-Investigator 2019 - 2024
Reducing Post-Hospital Mortality in HIV-Infected Adults in Tanzania awarded by National Institute of Mental Health Co-Investigator 2018 - 2024
A pragmatic trial of two strategies for implementing an effective eHealth HIV prevention program awarded by National Institute of Mental Health Co-Investigator 2018 - 2023

Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder awarded by National Institute on Drug Abuse Principal Investigator Subaward 2022 - 2027
Stepped care, peer-delivered intervention to improve ART adherence and SUD in primary care awarded by Centers for Disease Control & Prevention Principal Investigator Subaward 2022 - 2027
SOAR: Smartphones for Opioid Addiction Recovery awarded by Defense Advanced Research Projects Agency (DARPA) Principal Investigator Subaward 2021 - 2026
Peer-Delivered, Behavioral Activation Intervention to Improve Polysubstance Use and Retention in Telemedicine Mobile OUD Treatment in an Underserved, Rural Area awarded by Centers for Disease Control & Prevention Principal Investigator Subaward 2022 - 2025
Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network (CTN-0080) awarded by National Institute of Neurological Disorders & Stroke Principal Investigator Subaward 2020 - 2025
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (CTN-0100) awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2020 - 2025
NIDA Clinical Trials Network: Greater New York Node (CTN-0099) awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2019 - 2025
A Randomized Controlled Trial of sublingual versus extended-release buprenorphine with individuals leaving Carceral Settings awarded by National Institute on Drug Abuse Principal Investigator Subaward 2022 - 2024
Integrated Outpatient Treatment of Opioid Use Disorder and Injection-Related Infections awarded by National Institute on Drug Abuse Principal Investigator Subaward 2020 - 2024
Treating individuals leaving jail using extended-release medications: A Type 1 hybrid design of Vivitrol vs. CAM2038 for the treatment of opioid use disorder awarded by National Institute on Drug Abuse Principal Investigator Subaward 2019 - 2024
Massachusetts Justice Community Opioid Innovation Network (JCOIN) Clinical Research Center awarded by National Institute on Drug Abuse Principal Investigator Subaward 2019 - 2024
MassHEAL - Reducing overdose deaths 40% (2019-2023) awarded by National Institute on Drug Abuse Principal Investigator Subaward 2019 - 2024
Impact of Jail-Based Methadone on Overdose, Recidivism, HIV, and Health Outcomes and Costs in New York City, 2011-2017 awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2018 - 2024
Facilitating Opioid Care Connections: System level strategies to improve use of MAT and movement through the opioid care cascade for defendants in a new Opioid Court system awarded by National Institute of Mental Health Principal Investigator Subaward 2019 - 2023
Novel EtG Based Contingency Management for Alcohol in the Severely Mentally Ill awarded by National Institute on Alcohol Abuse & Alcoholism Principal Investigator Subaward 2017 - 2023

more ...

less ...

Background

education and training

Ph.D., Washington State University 2008
M.A., University of Montana 2003
B.A., University of Montana 2001

Contact

full name

Sean M. Murphy

primary email

smm2010@med.cornell.edu

VIVO Weill Cornell Medical College

Sean M. Murphy Professor of Population Health Sciences

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email